院前肾上腺素作为创伤性心脏骤停生存桥梁:全国倾向性评分匹配分析
该研究基于韩国院外心脏骤停登记库(2015-2021年),纳入成人创伤性心脏骤停患者,排除非创伤病因及心肺复苏持续时间<1分钟或>30分钟者,分析院前静脉肾上腺素使用与结局的关联。在22,105例合格患者中,809例(3.7%)接受了院前肾上腺素;倾向性评分匹配后分析1,614例(807对匹配)。院前肾上腺素与较高的出院生存率(5.1% vs 2.6%,调整OR 1.38,95%CI 1.36-1.39)和院前ROSC(12.8% vs 4.5%,调整OR 3.63,95%CI 2.39-5.51)相关;与良好神经结局(CPC 1-2)的关联仅在多变量调整后观察到(1.0% vs 0.5%,调整OR 1.11,95%CI 1.10-1.13)。作者认为,院前肾上腺素与出院生存和院前ROSC增加相关,但与良好神经结局的关联仍不确定,需进一步研究明确最佳时机和患者选择。
要点
- 在创伤性心脏骤停患者中,院前静脉肾上腺素与出院生存率升高相关(5.1% vs 2.6%,调整OR 1.38,95%CI 1.36-1.39)。
- 院前肾上腺素与院前ROSC升高相关(12.8% vs 4.5%,调整OR 3.63,95%CI 2.39-5.51)。
- 与良好神经结局(CPC 1-2)的关联仅在多变量调整后观察到(1.0% vs 0.5%,调整OR 1.11,95%CI 1.10-1.13),作者认为该关联仍不确定。
- 作者建议需进一步研究明确院前肾上腺素使用的最佳时机和患者选择。
适用人群与场景
- 成人创伤性心脏骤停患者,数据来自韩国院外心脏骤停登记库(2015-2021年)。
- 排除非创伤性病因者以及心肺复苏持续时间<1分钟或>30分钟者。
处置流程与药物剂量
- 院前静脉给予肾上腺素(原文未写明具体剂量、给药频次和疗程)。
研究设计与关键结果
- 研究类型:基于全国登记库的倾向性评分匹配分析;样本量:22,105例合格患者,其中809例(3.7%)接受院前肾上腺素;倾向性评分匹配(1:1)后分析1,614例(807对匹配)。
- 主要终点:出院生存率,肾上腺素组5.1% vs 对照组2.6%,调整OR 1.38(95%CI 1.36-1.39)。
- 次要终点:院前ROSC,肾上腺素组12.8% vs 对照组4.5%,调整OR 3.63(95%CI 2.39-5.51)。
- 次要终点:良好神经结局(CPC 1-2),肾上腺素组1.0% vs 对照组0.5%,调整OR 1.11(95%CI 1.10-1.13),该关联仅在多变量调整后观察到。
证据类型、等级与局限
- 证据类型:基于全国登记库的倾向性评分匹配分析(观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,院前肾上腺素与创伤性心脏骤停患者出院生存率和院前ROSC增加相关,但与良好神经结局的关联仍不确定。
- 作者建议需进一步研究明确院前肾上腺素使用的最佳时机和患者选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study investigated the association between prehospital intravenous epinephrine use and outcomes of traumatic cardiac arrest using propensity score matching in a nationwide registry.
METHODS: Data of adult patients with traumatic cardiac arrest from the Korean Out-of-Hospital Cardiac Arrest Registry (2015-2021) were analyzed. Patients with non-traumatic etiologies or cardiopulmonary resuscitation durations of <1 or >30 min were excluded. Prehospital epinephrine was administered. The primary outcome was survival to hospital discharge, while the secondary outcomes were prehospital return of spontaneous circulation (ROSC) and favorable neurological outcomes (Cerebral Performance Category (CPC) 1-2). Propensity score matching (1:1) and multivariate logistic regression analyses were performed using clinically relevant covariates.
RESULTS: Among the 22,105 eligible patients, 809 (3.7%) received prehospital epinephrine. After propensity score matching, 1614 patients (807 matched pairs) were analyzed. Prehospital epinephrine administration was associated with higher rates of survival to hospital discharge (5.1% vs. 2.6%, adjusted odds ratio (OR) 1.38, 95% confidence interval (CI): 1.36-1.39) and prehospital ROSC (12.8% vs. 4.5%, adjusted OR 3.63, 95% CI: 2.39-5.51). The association with favorable neurological outcomes was observed only after multivariable adjustment (1.0% vs. 0.5%, adjusted OR 1.11, 95% CI: 1.10-1.13).
CONCLUSION: Prehospital epinephrine administration in patients with traumatic cardiac arrest was associated with increased survival to hospital discharge and prehospital ROSC. However, its association with favorable neurological outcomes remains uncertain. Further studies are required to clarify the optimal timing and patient selection for prehospital epinephrine administration.
参考来源
- Chai HS, Park GJ, Kim YM, et al. Prehospital epinephrine as a bridge to survival in traumatic cardiac arrest: A nationwide propensity score-matched analysis. Am J Emerg Med. 2026. PMID: 42372567. doi:10.1016/j.ajem.2026.06.039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。